Support Your Metabolism with Clinically-Studied Ingredients

Mitolyn — 6 plant-based nutrients to boost mitochondrial health, energy & natural fat burning.

★★★★★ 127,000+ customers · 90-day money-back guarantee

Dr. Murray Raskind, MD

Geriatric Psychiatry Seattle, WA Male

NPI: 1679735922

Total Payments

$159,277

2022 Payments

$2,970

Companies

Transactions

Payment Breakdown by Category

Consulting$136,495 (85.7%)

Research$19,880 (12.5%)

Travel$2,354 (1.5%)

Food & Beverage$547.64 (0.3%)

Payments by Nature

Nature of Payment	Amount	Transactions	Share
Consulting Fee	$136,495	29	85.7%
Unspecified	$19,880	2	12.5%
Travel and Lodging	$2,354	6	1.5%
Food and Beverage	$547.64	5	0.3%

Payments by Type

General

$139,397

40 transactions

Research

$19,880

2 transactions

Top Paying Companies

Company	Total	Records	Latest Year
Takeda Development Center Americas, Inc.	$53,080	5	$0 (2017)
Takeda Pharmaceuticals U.S.A., Inc.	$47,200	4	$0 (2018)
Merck Sharp & Dohme Corporation	$46,900	20	$0 (2018)
EISAI INC.	$10,468	9	$0 (2022)
Millennium Pharmaceuticals, Inc.	$1,629	4	$0 (2017)

Payment History by Year

Year	Amount	Transactions	Top Company
2022	$2,970	1	EISAI INC. ($2,970)
2019	$7,498	8	Eisai Inc. ($7,498)
2018	$67,400	12	Takeda Pharmaceuticals U.S.A., Inc. ($47,200)
2017	$81,409	21	Takeda Development Center Americas, Inc. ($53,080)

All Payment Transactions

42 individual payment records from CMS Open Payments — Page 1 of 2

Date	Company	Product	Nature	Form	Amount	Type
02/02/2022	EISAI INC.	—	Consulting Fee	Cash or cash equivalent	$2,970.00	General
02/08/2019	Eisai Inc.	—	Consulting Fee	Cash or cash equivalent	$6,225.00	General
02/08/2019	Eisai Inc.	—	Travel and Lodging	Cash or cash equivalent	$551.60	General
02/08/2019	Eisai Inc.	—	Travel and Lodging	Cash or cash equivalent	$337.00	General
02/08/2019	Eisai Inc.	—	Travel and Lodging	Cash or cash equivalent	$136.00	General
02/08/2019	Eisai Inc.	—	Food and Beverage	Cash or cash equivalent	$114.83	General
02/08/2019	Eisai Inc.	—	Food and Beverage	Cash or cash equivalent	$58.43	General
02/08/2019	Eisai Inc.	—	Food and Beverage	Cash or cash equivalent	$40.29	General
02/08/2019	Eisai Inc.	—	Food and Beverage	Cash or cash equivalent	$34.86	General
08/21/2018	Merck Sharp & Dohme Corporation	MK-8931 (Drug)	Consulting Fee	Cash or cash equivalent	$1,800.00	General
Category: NEUROSCIENCE
08/12/2018	Takeda Pharmaceuticals U.S.A., Inc.	—	Consulting Fee	Cash or cash equivalent	$13,200.00	General
06/29/2018	Merck Sharp & Dohme Corporation	MK-8931 (Drug)	Consulting Fee	Cash or cash equivalent	$3,000.00	General
Category: NEUROSCIENCE
06/07/2018	Takeda Pharmaceuticals U.S.A., Inc.	—	Consulting Fee	Cash or cash equivalent	$11,800.00	General
05/15/2018	Merck Sharp & Dohme Corporation	MK-8931 (Drug)	Consulting Fee	Cash or cash equivalent	$800.00	General
Category: NEUROSCIENCE
04/17/2018	Merck Sharp & Dohme Corporation	MK-8931 (Drug)	Consulting Fee	Cash or cash equivalent	$3,600.00	General
Category: NEUROSCIENCE
04/05/2018	Takeda Pharmaceuticals U.S.A., Inc.	—	Consulting Fee	Cash or cash equivalent	$10,920.00	General
03/28/2018	Merck Sharp & Dohme Corporation	MK-8931 (Drug)	Consulting Fee	Cash or cash equivalent	$2,000.00	General
Category: NEUROSCIENCE
03/14/2018	Merck Sharp & Dohme Corporation	MK-8931 (Drug)	Consulting Fee	Cash or cash equivalent	$4,000.00	General
Category: NEUROSCIENCE
02/12/2018	Merck Sharp & Dohme Corporation	MK-8931 (Drug)	Consulting Fee	Cash or cash equivalent	$3,200.00	General
Category: NEUROSCIENCE
01/13/2018	Takeda Pharmaceuticals U.S.A., Inc.	—	Consulting Fee	Cash or cash equivalent	$11,280.00	General
01/09/2018	Merck Sharp & Dohme Corporation	MK-8931 (Drug)	Consulting Fee	Cash or cash equivalent	$1,800.00	General
Category: NEUROSCIENCE
12/07/2017	Millennium Pharmaceuticals, Inc.	—	Travel and Lodging	In-kind items and services	$968.62	General
12/07/2017	Millennium Pharmaceuticals, Inc.	—	Food and Beverage	In-kind items and services	$299.23	General
12/07/2017	Millennium Pharmaceuticals, Inc.	—	Travel and Lodging	In-kind items and services	$227.85	General
12/07/2017	Millennium Pharmaceuticals, Inc.	—	Travel and Lodging	In-kind items and services	$133.40	General

1 2 »

Research Studies & Clinical Trials

Study Name	Company	Amount	Records
Study to Qualify a Biomarker to Identify Subjects at Risk for MCI due to AD and to Evaluate Efficacy and Safety of Pioglitazone in Delaying Onset of MCI due to AD	Takeda Development Center Americas, Inc.	$19,880	2

About Dr. Murray Raskind, MD

Dr. Murray Raskind, MD is a Geriatric Psychiatry healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1679735922.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Murray Raskind, MD has received a total of $159,277 in payments from pharmaceutical and medical device companies, with $2,970 received in 2022. These payments were reported across 42 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($136,495).

16,000 Woodworking Plans

Step-by-step blueprints for any project. Beginner to expert.

Detailed schematics Cutting lists & materials Lifetime access — $67

★★★★★ 60-day guarantee

Get Instant Access

Practice Information

Specialty Geriatric Psychiatry
Location Seattle, WA
Active Since 06/27/2008
Last Updated 05/24/2019
Taxonomy Code 2084P0805X
Entity Type Individual
NPI Number 1679735922

Products in Payments

MK-8931 (Drug) $46,900
Actos (Drug) $19,880

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.